Oxford BioMedica PLC (OXB) — Defensive Interval Ratio
Oxford BioMedica PLC (OXB) has a Defensive Interval Ratio of 299 days as of June 2025. Defensive assets of GBX57.07 Million (cash GBX-, short-term investments GBX-, receivables GBX57.07 Million) cover 299 days of daily cash needs of GBX190.95K/day. Check Oxford BioMedica PLC tangible book value ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Oxford BioMedica PLC Defensive Interval Ratio (1999–2024)
This chart shows how Oxford BioMedica PLC's Defensive Interval Ratio has evolved across 26 annual periods from 1999 to 2024. As of June 2025, the ratio stands at 299 days, meaning defensive assets of GBX57.07 Million can fund 299 days of operations without new revenue. Also explore Oxford BioMedica PLC equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Oxford BioMedica PLC (1999–2024)
The table below presents the year-by-year Defensive Interval Ratio for Oxford BioMedica PLC from 1999 to 2024, covering 26 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see OXB market cap.
| Year | DIR (days) | Defensive Assets (GBX) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 264 days | GBX42.11 Million | GBX159.78K/day | GBX- | GBX- | ▲ +154 days |
| 2023 | 110 days | GBX13.34 Million | GBX121.41K/day | GBX- | GBX- | ▼ -243 days |
| 2022 | 352 days | GBX57.62 Million | GBX163.46K/day | GBX- | GBX23.00K | ▼ -110 days |
| 2021 | 462 days | GBX42.17 Million | GBX91.25K/day | GBX- | GBX74.00K | ▲ +103 days |
| 2020 | 359 days | GBX51.66 Million | GBX143.71K/day | GBX- | GBX239.00K | ▼ -99 days |
| 2019 | 458 days | GBX36.34 Million | GBX79.29K/day | GBX- | GBX2.72 Million | ▲ +46 days |
| 2018 | 412 days | GBX32.19 Million | GBX78.10K/day | GBX- | GBX- | ▲ +295 days |
| 2017 | 118 days | GBX7.02 Million | GBX59.62K/day | GBX- | GBX- | ▼ -253 days |
| 2016 | 370 days | GBX9.46 Million | GBX25.52K/day | GBX- | GBX- | ▲ +16 days |
| 2015 | 355 days | GBX12.80 Million | GBX36.08K/day | GBX- | GBX- | ▲ +198 days |
| 2014 | 157 days | GBX3.96 Million | GBX25.29K/day | GBX- | GBX- | ▲ +11 days |
| 2013 | 145 days | GBX1.68 Million | GBX11.55K/day | GBX- | GBX- | ▼ -536 days |
| 2012 | 681 days | GBX7.97 Million | GBX11.70K/day | GBX- | GBX5.11 Million | ▲ +183 days |
| 2011 | 498 days | GBX10.44 Million | GBX20.97K/day | GBX- | GBX7.50 Million | ▲ +139 days |
| 2010 | 359 days | GBX9.06 Million | GBX25.25K/day | GBX- | GBX5.60 Million | ▼ -226 days |
| 2009 | 584 days | GBX21.30 Million | GBX36.46K/day | GBX- | GBX18.50 Million | ▲ +85 days |
| 2008 | 499 days | GBX20.70 Million | GBX41.46K/day | GBX- | GBX13.75 Million | ▼ -43 days |
| 2007 | 542 days | GBX31.44 Million | GBX57.98K/day | GBX- | GBX27.18 Million | ▼ -1277 days |
| 2006 | 1820 days | GBX24.04 Million | GBX13.21K/day | GBX- | GBX20.50 Million | ▼ -2355 days |
| 2005 | 4175 days | GBX25.71 Million | GBX6.16K/day | GBX- | GBX23.50 Million | ▼ -37 days |
| 2004 | 4212 days | GBX20.09 Million | GBX4.77K/day | GBX- | GBX17.50 Million | ▼ -3969 days |
| 2003 | 8181 days | GBX33.64 Million | GBX4.11K/day | GBX- | GBX31.70 Million | ▲ +7660 days |
| 2002 | 521 days | GBX1.79 Million | GBX3.44K/day | GBX- | GBX- | ▲ +47 days |
| 2001 | 475 days | GBX2.28 Million | GBX4.81K/day | GBX- | GBX- | ▲ +256 days |
| 2000 | 219 days | GBX804.00K | GBX3.67K/day | GBX- | GBX- | ▲ +106 days |
| 1999 | 113 days | GBX249.00K | GBX2.19K/day | GBX- | GBX- | — |